Oregon News

The study may redefine care for many people at the earliest stage of their treatment.

Breastfed babies’ immune systems are better equipped to fight infections and other illnesses. Hear from a caregiver about the program offering lifesaving donor milk to new families in Hood River.

Get to know the women of the Immune Monitoring Laboratory and how their curiosity, tenacity and passion are driving progress in cancer research at Providence Cancer Institute.

Dr. Natasha Edwin advocates for making more quality clinical trials available for patients in rural communities.

A new study aims to move cervical cancer care forward and improve the chance of long-term remission for more patients.

A targeted therapy being evaluated in a clinical trial may improve survival for high-risk patients with diffuse large B-cell lymphoma.

Marge received treatment for pancreatic cancer at Providence Cancer Institute and then volunteered in the infusion center to help the care team that supported her.

Catch the 2025 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.

NEWS RELEASE: Providence Oregon and Aetna, a CVS Health company, have reached a multi-year agreement that brings Providence hospitals, clinics, and physicians across Oregon back in-network.

Providence Breast Care and Breast Surgery Clinics launch Prevention4ME, a groundbreaking program to empower women with personalized breast cancer risk assessments and proactive screening options.

Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science.

New studies at Providence Cancer Institute offer hope to patients with limited treatment options.

Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.

Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.

A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.

Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.

Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.

In July 2025, Providence had the honor of celebrating the 150th anniversary of Providence St. Vincent, Oregon’s first hospital.

After careful consideration, we have made the difficult decision to close our inpatient obstetric and newborn care services at Providence Seaside Hospital.